KindlyMD Approves Stock Buyback Plan, Shares Rise in Pre-Market Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: NASDAQ.COM
Share Repurchase Program: Kindly MD, Inc. (NAKA) has announced a board-approved share repurchase program for its outstanding common stock, allowing the company to buy back shares in various ways.
Board Flexibility: The board retains the option to modify or terminate the share repurchase program as deemed necessary.
Stock Performance: In pre-market trading, NAKA shares are priced at $0.38, reflecting a 4.21 percent increase on the Nasdaq.
Disclaimer: The views expressed in the announcement are those of the author and do not necessarily represent Nasdaq, Inc.
Analyst Views on NAKA
Wall Street analysts forecast NAKA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NAKA is 1.25 USD with a low forecast of 1.00 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.376
Low
1.00
Averages
1.25
High
1.50
Current: 0.376
Low
1.00
Averages
1.25
High
1.50
About NAKA
Kindly MD, Inc. is a Bitcoin-native holding company. The Company focuses on both healthcare and Bitcoin treasury management. It is focused on holistic pain management and reducing the impact of the opioid epidemic. Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts, as well as offered on a fee-for-service basis. The Company offers both in-person and telemedicine options for patients. It provides management of pain, functional medicine, cognitive behavioral therapy, addiction, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Its services include mental health, medical cards, medication management, sleep support, pain treatment, and weight loss. It operates the Bitcoin financial services line of business under the Nakamoto brand. Its wholly owned subsidiary is Nakamoto Holdings Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
